Evidence map›Paper›PMID 39843850›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2025

Endocannabinoid contributions to the perception of socially relevant, affective touch in humans.

Madeleine R Jones, Connor J Haggarty, Gavin N Petrie, Abigail R Lunge, India Morrison, Matthew N Hill, Markus Heilig, Leah M Mayo

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Madeleine R Jones *Department of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.
Connor J Haggarty *Department of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0001-6678-0570
Gavin N PetrieDepartment of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Abigail R LungeDepartment of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
India MorrisonDepartment of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.
Matthew N HillDepartment of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Markus HeiligDepartment of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.
Leah M MayoDepartment of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden. leah.mayo@ucalgary.ca.ORCID http://orcid.org/0000-0002-0645-4869

Funding

Brain and Behavior Research Foundation (Brain & Behavior Research Foundation) 27094Hotchkiss Brain Institute, University of Calgary (HBI, U of C) Parker Psychedelics Research ChairVetenskapsrådet (Swedish Research Council) 2013-07434
6 · The paper itself

Abstract

Social relationships are central to well-being. A subgroup of afferent nerve fibers, C-tactile (CT) afferents, are primed to respond to affective, socially relevant touch and may mitigate the effects of stress. The endocannabinoid ligand anandamide (AEA) modulates both social reward and stress. We thus hypothesized that AEA levels would be associated with the perceived pleasantness of affective touch in humans. Across two studies, we explored perceptions of affective, socially relevant touch and general affective stimuli. In study 1, adult participants (N = 101) were recruited based on presence (CM+) or absence (CM-) of documented childhood maltreatment (N = 52 CM+; N = 49 CM-). In study 2, healthy individuals were randomized to receive an inhibitor of fatty acid amide hydrolase (FAAH; PF-04457845) to increase AEA levels (n = 16) or placebo (n = 29). Outcomes included self-report ratings of touch pleasantness and intensity, valence and arousal ratings of affective images, and plasma levels of endocannabinoids AEA and 2-AG, cortisol, and oxytocin. In study 1, higher AEA levels were associated with a reduced preference for affective, CT-optimal touch. In study 2, pharmacological elevation of AEA resulted in reduced preference for affective touch. These effects were specific to social processing, as AEA levels were not related to ratings of affective images. In contrast to our hypothesis, elevated AEA was associated with reduced pleasantness ratings of CT-optimal, affective touch. This provides novel, in-human data linking AEA to social processing, adding nuance to the rationale for its use as a potential novel therapeutic target in disordered in social processing.

Indexed as

AffectArachidonic AcidsEndocannabinoidsPolyunsaturated AlkamidesSocial PerceptionTouch PerceptionAdolescentAdultAmidohydrolasesFatty Acid Amide HydrolasesFemaleHumansHydrocortisoneMaleOxytocinYoung AdultAmidohydrolasesanandamideArachidonic AcidsEndocannabinoidsFatty Acid Amide HydrolasesHydrocortisoneOxytocinPolyunsaturated Alkamides

Identifiers

PMID39843850
PMCPMC11914470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.